About the Business

Overview

Expressions of interest are now open for a new venture capital fund targeting scalable innovation in health, medtech, and deeptech. Designed for sophisticated investors, the fund offers exclusive access to early-stage ventures emerging from one of the Asia-Pacific’s most successful commercialisation platforms.

Structured with institutional discipline and driven by a long-term impact thesis, this opportunity aligns capital with global healthcare innovation and transformation.

Available strictly to:

Sophisticated Investors (Australia, as defined under the Corporations Act)
Accredited/Expert/Institutional Investors (Singapore, as defined under Securities and Futures Act 2001)

Why This Opportunity?

This fund has been purpose-built to support high-growth startups tackling critical challenges in health and wellbeing. Through its strategic partnership with a leading healthtech accelerator, investors gain a front-row seat to emerging ventures poised to redefine care delivery, digital health, and preventative medicine.

Key Highlights

Exclusive Pipeline Access: Direct deal flow from a top-tier accelerator with a track record of commercialising successful ventures.
Deep Industry Focus: Investment mandate centred on healthcare, medtech, and deeptech – sectors driving long-term change in global wellbeing.
Institutional-Grade Structure: Led by experienced operators, with robust governance and scalable investment frameworks.

Why Enquire?

Early-stage health innovation remains undercapitalised in APAC.
Governments and institutions are backing future-focused health and technology solutions.
Investors are increasingly demanding impact-driven, future-proof portfolios.
The fund has a curated, investment-ready pipeline of ventures already in development.

Next Steps

This is an exclusive opportunity to participate in a new chapter of health and innovation investment. If you’re an active wholesale investor seeking early access to institutional-grade venture capital opportunities in the Asia-Pacific, we invite your confidential enquiry.

Submit an EOI to learn more.

Disclaimer: Eden Exchange Pty Ltd (ACN 152 787 212) is a Corporate Authorised Representative (AR No. 001310143) of Melbourne Venture Securities Pty Ltd (ACN 106 186 389), the holder of Australian Financial Services Licence No. 277465. This opportunity is only available to wholesale investors as defined under the Corporations Act or accredited/institutional investors under MAS regulations.